PHASE II STUDY OF ERLOTINIB AS A FIRST-LINE THERAPY FOR NON-SMALL-CELL LUNG CANCER PATIENTS ACCORDING TO THEIR CLINICAL PREDICTORS

被引：0
作者：
Lee, D. H. [1 ]
Kim, H. T. [2 ]
Kim, S. [1 ]
Suh, C. [1 ]
Lee, J. [1 ]
机构：
[1] Asan Med Ctr, Dept Internal Med, Div Oncol, Seoul, South Korea
[2] Natl Canc Ctr, Res Inst & Hosp, Ctr Lung Canc, Goyang, South Korea
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
[21]   Phase-I/II Study of Bortezomib in Combination with Carboplatin and Bevacizumab as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer [J].
Piperdi, Bilal ;
Walsh, William V. ;
Bradley, Kendra ;
Zhou, Zheng ;
Bathini, Venu ;
Hanrahan-Boshes, Meredith ;
Hutchinson, Lloyd ;
Perez-Soler, Roman .
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) :1032-1040
[22]   PHASE II TRIAL OF ERLOTINIB AS FIRST-LINE THERAPY IN NON-SMALL CELL LUNG CANCER OVER-EXPRESSING EGFR [J].
Murphy, Felicity ;
Church, David N. ;
Medley, Louise ;
Davies, J. M. ;
Breen, David ;
Clelland, Colin ;
Mackintosh, David ;
Mugalaasi, Hood ;
Butler, Rachel ;
Talbot, Denis C. .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) :S1250-S1250
[23]   Cost-effectiveness of first-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy [J].
Khan, Iftekhar ;
Morris, Stephen ;
Hackshaw, Allan ;
Lee, Siow-Ming .
BMJ OPEN, 2015, 5 (07)
[24]   Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer [J].
F Cappuzzo ;
S Novello ;
F De Marinis ;
V Franciosi ;
M Maur ;
A Ceribelli ;
V Lorusso ;
F Barbieri ;
L Castaldini ;
E Crucitta ;
L Marini ;
S Bartolini ;
G V Scagliotti ;
L Crinò .
British Journal of Cancer, 2005, 93 :29-34
[25]   Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer [J].
Cappuzzo, F ;
Novello, S ;
De Marinis, F ;
Franciosi, V ;
Maur, M ;
Ceribelli, A ;
Lorusso, V ;
Barbieri, F ;
Castaldini, L ;
Crucitta, E ;
Marini, L ;
Bartolini, S ;
Scagliotti, GV ;
Crinò, L .
BRITISH JOURNAL OF CANCER, 2005, 93 (01) :29-34
[26]   Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer [J].
Lorusso, V ;
Carpagnano, F ;
Frasci, G ;
Panza, N ;
Di Rienzo, G ;
Cisternino, ML ;
Napoli, G ;
Orlando, S ;
Cinieri, S ;
Brunetti, C ;
Palazzo, S ;
De Lena, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) :405-411
[27]   First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: A multicenter phase II study [J].
Georgoulias, V ;
Androulakis, N ;
Dimopoulos, AM ;
Kourousis, C ;
Kakolyris, S ;
Papadakis, E ;
Apostolopoulou, F ;
Papadimitriou, C ;
Vossos, A ;
Agelidou, M ;
Heras, P ;
Tzannes, S ;
Vlachonicolis, J ;
Mavromanolakis, E ;
Hatzidaki, D .
ANNALS OF ONCOLOGY, 1998, 9 (03) :331-334
[28]   Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer [J].
Lorusso, V ;
Crucitta, E ;
Panza, N ;
Silvestris, N ;
Guida, M ;
Carpagnano, F ;
Mancarella, S ;
Sambiasi, D ;
De Lena, M .
ANNALS OF ONCOLOGY, 2002, 13 (12) :1862-1867
[29]   Erlotinib in First-line Therapy for Non-small Cell Lung Cancer: A Prospective Phase II Study (vol 31, pg 3457, 2011) [J].
Cecere, S. C. ;
Cannella, L. ;
Rossetti, S. ;
Di Napoli, M. ;
Pisano, C. ;
Fiore, F. ;
Striano, S. ;
Marra, L. ;
Pignata, S. ;
Facchini, G. .
ANTICANCER RESEARCH, 2012, 32 (08) :3592-3592
[30]   Gefitinib as first-line, compassionate use therapy in patients with advanced non-small-cell lung cancer [J].
Argiris, A ;
Mittal, N .
LUNG CANCER, 2004, 43 (03) :317-322
12345